Global Auxins Market Outlook, In-Depth Analysis & Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Introduction to Auxins: Definition, Properties, and Key Attributes
• 1.2 Market Segmentation by Type
  • 1.2.1 Global Auxins Market Size by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Natural Auxins
  • 1.2.3 Synthesis Auxins
• 1.3 Market Segmentation by Application
  • 1.3.1 Global Auxins Market Size by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Agriculture
  • 1.3.3 Scientific Research
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Auxins Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Auxins Revenue by Region
  • 2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
  • 2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
  • 2.2.3 Global Revenue Market Share by Region (2020-2031)
• 2.3 Global Auxins Sales Estimates and Forecasts 2020-2031
• 2.4 Global Auxins Sales by Region
  • 2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
  • 2.4.2 Historical and Forecasted Sales by Region (2020-2031)
  • 2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
  • 2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

• 3.1 Global Auxins Production Capacity and Utilization Rates (2020-2031)
• 3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
• 3.3 Regional Production Dynamics
  • 3.3.1 Historic Production by Region (2020-2025)
  • 3.3.2 Forecasted Production by Region (2026-2031)
  • 3.3.3 Production Market Share by Region (2020-2031)
  • 3.3.4 Regulatory and Trade Policy Impact on Production
  • 3.3.5 Production Capacity Enablers and Constraints
• 3.4 Key Regional Production Hubs
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 China
  • 3.4.4 Japan
  • 3.4.5 India
  • 3.4.6 Southeast Asia
  • 3.4.7 Brazil

4 Competition by Manufacturers

• 4.1 Global Auxins Sales by Manufacturers
  • 4.1.1 Global Sales Volume by Manufacturers (2020-2025)
  • 4.1.2 Global Top 5 and Top 10 Manufacturers'Market Share by Sales Volume (2024)
• 4.2 Global Auxins Manufacturer Revenue Rankings and Tiers
  • 4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
  • 4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
  • 4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
• 4.3 Manufacturer Profitability Profiles and Pricing Strategies
  • 4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
  • 4.3.2 Manufacturer-Level Price Trends (2020-2025)
• 4.4 Key Manufacturers Manufacturing Base and Headquarters
• 4.5 Main Product Type Market Size by Manufacturers
  • 4.5.1 Natural Auxins Market Size by Manufacturers
  • 4.5.2 Synthesis Auxins Market Size by Manufacturers
• 4.6 Global Auxins Market Concentration and Dynamics
  • 4.6.1 Global Market Concentration (CR5 and HHI)
  • 4.6.2 Entrant/Exit Impact Analysis
  • 4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

• 5.1 Global Auxins Sales Performance by Type
  • 5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
  • 5.1.2 Global Sales Market Share by Type (2020-2031)
• 5.2 Global Auxins Revenue Trends by Type
  • 5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
  • 5.2.2 Global Revenue Market Share by Type (2020-2031)
• 5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
• 5.4 Product Technology Differentiation
• 5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
  • 5.5.1 High-Growth Niches and Adoption Drivers
  • 5.5.2 Profitability Hotspots and Cost Drivers
  • 5.5.3 Substitution Threats

6 Global Downstream Application Analysis

• 6.1 Global Auxins Sales by Application
  • 6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
  • 6.1.2 Global Sales Market Share by Application (2020-2031)
  • 6.1.3 High-Growth Application Identification
  • 6.1.4 Emerging Application Case Studies
• 6.2 Global Auxins Revenue by Application
  • 6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
  • 6.2.2 Revenue Market Share by Application (2020-2031)
• 6.3 Global Pricing Dynamics by Application (2020-2031)
• 6.4 Downstream Customer Analysis
  • 6.4.1 Top Customers by Region
  • 6.4.2 Top Customers by Application

7 North America

• 7.1 North America Sales Volume and Revenue (2020-2031)
• 7.2 North America Key Manufacturers Sales Revenue in 2024
• 7.3 North America Auxins Sales and Revenue by Type (2020-2031)
• 7.4 North America Auxins Sales and Revenue by Application (2020-2031)
• 7.5 North America Growth Accelerators and Market Barriers
• 7.6 North America Auxins Market Size by Country
  • 7.6.1 North America Revenue by Country
  • 7.6.2 North America Sales Trends by Country
  • 7.6.3 US
  • 7.6.4 Canada
  • 7.6.5 Mexico

8 Europe

• 8.1 Europe Sales Volume and Revenue (2020-2031)
• 8.2 Europe Key Manufacturers Sales Revenue in 2024
• 8.3 Europe Auxins Sales and Revenue by Type (2020-2031)
• 8.4 Europe Auxins Sales and Revenue by Application (2020-2031)
• 8.5 Europe Growth Accelerators and Market Barriers
• 8.6 Europe Auxins Market Size by Country
  • 8.6.1 Europe Revenue by Country
  • 8.6.2 Europe Sales Trends by Country
  • 8.6.3 Germany
  • 8.6.4 France
  • 8.6.5 U.K.
  • 8.6.6 Italy
  • 8.6.7 Russia

9 Asia-Pacific

• 9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
• 9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
• 9.3 Asia-Pacific Auxins Sales and Revenue by Type (2020-2031)
• 9.4 Asia-Pacific Auxins Sales and Revenue by Application (2020-2031)
• 9.5 Asia-Pacific Auxins Market Size by Region
  • 9.5.1 Asia-Pacific Revenue by Region
  • 9.5.2 Asia-Pacific Sales Trends by Region
• 9.6 Asia-Pacific Growth Accelerators and Market Barriers
• 9.7 Southeast Asia
  • 9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
  • 9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
• 9.8 China
• 9.9 Japan
• 9.10 South Korea
• 9.11 China Taiwan
• 9.12 India

10 Central and South America

• 10.1 Central and South America Sales Volume and Revenue (2020-2031)
• 10.2 Central and South America Key Manufacturers Sales Revenue in 2024
• 10.3 Central and South America Auxins Sales and Revenue by Type (2020-2031)
• 10.4 Central and South America Auxins Sales and Revenue by Application (2020-2031)
• 10.5 Central and South America Investment Opportunities and Key Challenges
• 10.6 Central and South America Auxins Market Size by Country
  • 10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 10.6.2 Brazil
  • 10.6.3 Argentina

11 Middle East and Africa

• 11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
• 11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
• 11.3 Middle East and Africa Auxins Sales and Revenue by Type (2020-2031)
• 11.4 Middle East and Africa Auxins Sales and Revenue by Application (2020-2031)
• 11.5 Middle East and Africa Investment Opportunities and Key Challenges
• 11.6 Middle East and Africa Auxins Market Size by Country
  • 11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
  • 11.6.2 GCC Countries
  • 11.6.3 Turkey
  • 11.6.4 Egypt
  • 11.6.5 South Africa

12 Corporate Profile

• 12.1 CANNA
  • 12.1.1 CANNA Corporation Information
  • 12.1.2 CANNA Business Overview
  • 12.1.3 CANNA Auxins Product Models, Descriptions and Specifications
  • 12.1.4 CANNA Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.1.5 CANNA Auxins Sales by Product in 2024
  • 12.1.6 CANNA Auxins Sales by Application in 2024
  • 12.1.7 CANNA Auxins Sales by Geographic Area in 2024
  • 12.1.8 CANNA Auxins SWOT Analysis
  • 12.1.9 CANNA Recent Developments
• 12.2 Azoo
  • 12.2.1 Azoo Corporation Information
  • 12.2.2 Azoo Business Overview
  • 12.2.3 Azoo Auxins Product Models, Descriptions and Specifications
  • 12.2.4 Azoo Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.2.5 Azoo Auxins Sales by Product in 2024
  • 12.2.6 Azoo Auxins Sales by Application in 2024
  • 12.2.7 Azoo Auxins Sales by Geographic Area in 2024
  • 12.2.8 Azoo Auxins SWOT Analysis
  • 12.2.9 Azoo Recent Developments
• 12.3 Duchefa Biochemie
  • 12.3.1 Duchefa Biochemie Corporation Information
  • 12.3.2 Duchefa Biochemie Business Overview
  • 12.3.3 Duchefa Biochemie Auxins Product Models, Descriptions and Specifications
  • 12.3.4 Duchefa Biochemie Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.3.5 Duchefa Biochemie Auxins Sales by Product in 2024
  • 12.3.6 Duchefa Biochemie Auxins Sales by Application in 2024
  • 12.3.7 Duchefa Biochemie Auxins Sales by Geographic Area in 2024
  • 12.3.8 Duchefa Biochemie Auxins SWOT Analysis
  • 12.3.9 Duchefa Biochemie Recent Developments
• 12.4 Nutrico
  • 12.4.1 Nutrico Corporation Information
  • 12.4.2 Nutrico Business Overview
  • 12.4.3 Nutrico Auxins Product Models, Descriptions and Specifications
  • 12.4.4 Nutrico Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.4.5 Nutrico Auxins Sales by Product in 2024
  • 12.4.6 Nutrico Auxins Sales by Application in 2024
  • 12.4.7 Nutrico Auxins Sales by Geographic Area in 2024
  • 12.4.8 Nutrico Auxins SWOT Analysis
  • 12.4.9 Nutrico Recent Developments
• 12.5 Kenya Biologics Ltd
  • 12.5.1 Kenya Biologics Ltd Corporation Information
  • 12.5.2 Kenya Biologics Ltd Business Overview
  • 12.5.3 Kenya Biologics Ltd Auxins Product Models, Descriptions and Specifications
  • 12.5.4 Kenya Biologics Ltd Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.5.5 Kenya Biologics Ltd Auxins Sales by Product in 2024
  • 12.5.6 Kenya Biologics Ltd Auxins Sales by Application in 2024
  • 12.5.7 Kenya Biologics Ltd Auxins Sales by Geographic Area in 2024
  • 12.5.8 Kenya Biologics Ltd Auxins SWOT Analysis
  • 12.5.9 Kenya Biologics Ltd Recent Developments
• 12.6 BASF SE
  • 12.6.1 BASF SE Corporation Information
  • 12.6.2 BASF SE Business Overview
  • 12.6.3 BASF SE Auxins Product Models, Descriptions and Specifications
  • 12.6.4 BASF SE Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.6.5 BASF SE Recent Developments
• 12.7 Bayer CropScience
  • 12.7.1 Bayer CropScience Corporation Information
  • 12.7.2 Bayer CropScience Business Overview
  • 12.7.3 Bayer CropScience Auxins Product Models, Descriptions and Specifications
  • 12.7.4 Bayer CropScience Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.7.5 Bayer CropScience Recent Developments
• 12.8 Syngenta AG
  • 12.8.1 Syngenta AG Corporation Information
  • 12.8.2 Syngenta AG Business Overview
  • 12.8.3 Syngenta AG Auxins Product Models, Descriptions and Specifications
  • 12.8.4 Syngenta AG Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.8.5 Syngenta AG Recent Developments
• 12.9 Corteva Agriscience
  • 12.9.1 Corteva Agriscience Corporation Information
  • 12.9.2 Corteva Agriscience Business Overview
  • 12.9.3 Corteva Agriscience Auxins Product Models, Descriptions and Specifications
  • 12.9.4 Corteva Agriscience Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.9.5 Corteva Agriscience Recent Developments
• 12.10 Adama Agricultural Solutions Ltd.
  • 12.10.1 Adama Agricultural Solutions Ltd. Corporation Information
  • 12.10.2 Adama Agricultural Solutions Ltd. Business Overview
  • 12.10.3 Adama Agricultural Solutions Ltd. Auxins Product Models, Descriptions and Specifications
  • 12.10.4 Adama Agricultural Solutions Ltd. Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.10.5 Adama Agricultural Solutions Ltd. Recent Developments
• 12.11 Sumitomo Chemical Co., Ltd.
  • 12.11.1 Sumitomo Chemical Co., Ltd. Corporation Information
  • 12.11.2 Sumitomo Chemical Co., Ltd. Business Overview
  • 12.11.3 Sumitomo Chemical Co., Ltd. Auxins Product Models, Descriptions and Specifications
  • 12.11.4 Sumitomo Chemical Co., Ltd. Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.11.5 Sumitomo Chemical Co., Ltd. Recent Developments
• 12.12 UPL Limited
  • 12.12.1 UPL Limited Corporation Information
  • 12.12.2 UPL Limited Business Overview
  • 12.12.3 UPL Limited Auxins Product Models, Descriptions and Specifications
  • 12.12.4 UPL Limited Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.12.5 UPL Limited Recent Developments
• 12.13 Valent BioSciences Corporation
  • 12.13.1 Valent BioSciences Corporation Corporation Information
  • 12.13.2 Valent BioSciences Corporation Business Overview
  • 12.13.3 Valent BioSciences Corporation Auxins Product Models, Descriptions and Specifications
  • 12.13.4 Valent BioSciences Corporation Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.13.5 Valent BioSciences Corporation Recent Developments
• 12.14 Arysta LifeScience Corporation
  • 12.14.1 Arysta LifeScience Corporation Corporation Information
  • 12.14.2 Arysta LifeScience Corporation Business Overview
  • 12.14.3 Arysta LifeScience Corporation Auxins Product Models, Descriptions and Specifications
  • 12.14.4 Arysta LifeScience Corporation Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.14.5 Arysta LifeScience Corporation Recent Developments
• 12.15 PI Industries Ltd.
  • 12.15.1 PI Industries Ltd. Corporation Information
  • 12.15.2 PI Industries Ltd. Business Overview
  • 12.15.3 PI Industries Ltd. Auxins Product Models, Descriptions and Specifications
  • 12.15.4 PI Industries Ltd. Auxins Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
  • 12.15.5 PI Industries Ltd. Recent Developments

13 Value Chain and Supply-Chain Analysis

• 13.1 Auxins Industry Chain
• 13.2 Auxins Upstream Materials Analysis
  • 13.2.1 Raw Materials
  • 13.2.2 Key Suppliers Market Share & Risk Assessment
• 13.3 Auxins Integrated Production Analysis
  • 13.3.1 Manufacturing Footprint Analysis
  • 13.3.2 Production Technology Overview
  • 13.3.3 Regional Cost Drivers
• 13.4 Auxins Sales Channels and Distribution Networks
  • 13.4.1 Sales Channels
  • 13.4.2 Distributors

14 Auxins Market Dynamics

• 14.1 Industry Trends and Evolution
• 14.2 Market Growth Drivers and Emerging Opportunities
• 14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Auxins Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
    • 16.1.1.1 Research Programs/Design
    • 16.1.1.2 Market Size Estimation
    • 16.1.1.3 Market Breakdown and Data Triangulation
  • 16.1.2 Data Source
    • 16.1.2.1 Secondary Sources
    • 16.1.2.2 Primary Sources
• 16.2 Author Details

List of Tables

Table 1. Global Auxins Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Auxins Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Auxins Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Auxins Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Auxins Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Auxins Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 7. Global Auxins Sales by Region (2020-2025) & (MT)

Table 8. Global Auxins Sales by Region (2026-2031) & (MT)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Auxins Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 11. Global Auxins Production by Region (2020-2025) & (MT)

Table 12. Global Auxins Production by Region (2026-2031) & (MT)

Table 13. Global Auxins Sales by Manufacturers (2020-2025) & (MT)

Table 14. Global Auxins Sales Share by Manufacturers (2020-2025)

Table 15. Global Auxins Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Auxins Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers'Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Auxins by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Auxins as of 2024)

Table 19. Global Auxins Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Auxins Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)

Table 21. Key Manufacturers Auxins Manufacturing Base and Headquarters

Table 22. Global Auxins Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) - Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Auxins Sales by Type (2020-2025) & (MT)

Table 26. Global Auxins Sales by Type (2026-2031) & (MT)

Table 27. Global Auxins Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Auxins Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Auxins ASP by Type (2020-2031) & (USD/MT)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Auxins Sales by Application (2020-2025) & (MT)

Table 32. Global Auxins Sales by Application (2026-2031) & (MT)

Table 33. Auxins High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Auxins Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Auxins Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Auxins ASP by Application (2020-2031) & (USD/MT)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Auxins Growth Accelerators and Market Barriers

Table 40. North America Auxins Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Auxins Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Auxins Growth Accelerators and Market Barriers

Table 43. Europe Auxins Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Auxins Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Auxins Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Auxins Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Auxins Growth Accelerators and Market Barriers

Table 48. Southeast Asia Auxins Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Auxins Investment Opportunities and Key Challenges

Table 50. Central and South America Auxins Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Auxins Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Auxins Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. CANNA Corporation Information

Table 54. CANNA Description and Major Businesses

Table 55. CANNA Product Models, Descriptions and Specifications

Table 56. CANNA Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 57. CANNA Sales Value Proportion by Product in 2024

Table 58. CANNA Sales Value Proportion by Application in 2024

Table 59. CANNA Sales Value Proportion by Geographic Area in 2024

Table 60. CANNA Auxins SWOT Analysis

Table 61. CANNA Recent Developments

Table 62. Azoo Corporation Information

Table 63. Azoo Description and Major Businesses

Table 64. Azoo Product Models, Descriptions and Specifications

Table 65. Azoo Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 66. Azoo Sales Value Proportion by Product in 2024

Table 67. Azoo Sales Value Proportion by Application in 2024

Table 68. Azoo Sales Value Proportion by Geographic Area in 2024

Table 69. Azoo Auxins SWOT Analysis

Table 70. Azoo Recent Developments

Table 71. Duchefa Biochemie Corporation Information

Table 72. Duchefa Biochemie Description and Major Businesses

Table 73. Duchefa Biochemie Product Models, Descriptions and Specifications

Table 74. Duchefa Biochemie Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 75. Duchefa Biochemie Sales Value Proportion by Product in 2024

Table 76. Duchefa Biochemie Sales Value Proportion by Application in 2024

Table 77. Duchefa Biochemie Sales Value Proportion by Geographic Area in 2024

Table 78. Duchefa Biochemie Auxins SWOT Analysis

Table 79. Duchefa Biochemie Recent Developments

Table 80. Nutrico Corporation Information

Table 81. Nutrico Description and Major Businesses

Table 82. Nutrico Product Models, Descriptions and Specifications

Table 83. Nutrico Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 84. Nutrico Sales Value Proportion by Product in 2024

Table 85. Nutrico Sales Value Proportion by Application in 2024

Table 86. Nutrico Sales Value Proportion by Geographic Area in 2024

Table 87. Nutrico Auxins SWOT Analysis

Table 88. Nutrico Recent Developments

Table 89. Kenya Biologics Ltd Corporation Information

Table 90. Kenya Biologics Ltd Description and Major Businesses

Table 91. Kenya Biologics Ltd Product Models, Descriptions and Specifications

Table 92. Kenya Biologics Ltd Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Kenya Biologics Ltd Sales Value Proportion by Product in 2024

Table 94. Kenya Biologics Ltd Sales Value Proportion by Application in 2024

Table 95. Kenya Biologics Ltd Sales Value Proportion by Geographic Area in 2024

Table 96. Kenya Biologics Ltd Auxins SWOT Analysis

Table 97. Kenya Biologics Ltd Recent Developments

Table 98. BASF SE Corporation Information

Table 99. BASF SE Description and Major Businesses

Table 100. BASF SE Product Models, Descriptions and Specifications

Table 101. BASF SE Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 102. BASF SE Recent Developments

Table 103. Bayer CropScience Corporation Information

Table 104. Bayer CropScience Description and Major Businesses

Table 105. Bayer CropScience Product Models, Descriptions and Specifications

Table 106. Bayer CropScience Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 107. Bayer CropScience Recent Developments

Table 108. Syngenta AG Corporation Information

Table 109. Syngenta AG Description and Major Businesses

Table 110. Syngenta AG Product Models, Descriptions and Specifications

Table 111. Syngenta AG Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 112. Syngenta AG Recent Developments

Table 113. Corteva Agriscience Corporation Information

Table 114. Corteva Agriscience Description and Major Businesses

Table 115. Corteva Agriscience Product Models, Descriptions and Specifications

Table 116. Corteva Agriscience Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 117. Corteva Agriscience Recent Developments

Table 118. Adama Agricultural Solutions Ltd. Corporation Information

Table 119. Adama Agricultural Solutions Ltd. Description and Major Businesses

Table 120. Adama Agricultural Solutions Ltd. Product Models, Descriptions and Specifications

Table 121. Adama Agricultural Solutions Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 122. Adama Agricultural Solutions Ltd. Recent Developments

Table 123. Sumitomo Chemical Co., Ltd. Corporation Information

Table 124. Sumitomo Chemical Co., Ltd. Description and Major Businesses

Table 125. Sumitomo Chemical Co., Ltd. Product Models, Descriptions and Specifications

Table 126. Sumitomo Chemical Co., Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 127. Sumitomo Chemical Co., Ltd. Recent Developments

Table 128. UPL Limited Corporation Information

Table 129. UPL Limited Description and Major Businesses

Table 130. UPL Limited Product Models, Descriptions and Specifications

Table 131. UPL Limited Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 132. UPL Limited Recent Developments

Table 133. Valent BioSciences Corporation Corporation Information

Table 134. Valent BioSciences Corporation Description and Major Businesses

Table 135. Valent BioSciences Corporation Product Models, Descriptions and Specifications

Table 136. Valent BioSciences Corporation Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 137. Valent BioSciences Corporation Recent Developments

Table 138. Arysta LifeScience Corporation Corporation Information

Table 139. Arysta LifeScience Corporation Description and Major Businesses

Table 140. Arysta LifeScience Corporation Product Models, Descriptions and Specifications

Table 141. Arysta LifeScience Corporation Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 142. Arysta LifeScience Corporation Recent Developments

Table 143. PI Industries Ltd. Corporation Information

Table 144. PI Industries Ltd. Description and Major Businesses

Table 145. PI Industries Ltd. Product Models, Descriptions and Specifications

Table 146. PI Industries Ltd. Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 147. PI Industries Ltd. Recent Developments

Table 148. Key Raw Materials Distribution

Table 149. Raw Materials Key Suppliers

Table 150. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 151. Milestones in Production Technology Evolution

Table 152. Distributors List

Table 153. Market Trends and Market Evolution

Table 154. Market Drivers and Opportunities

Table 155. Market Challenges, Risks, and Restraints

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

List of Figures

Figure 1. Auxins Product Picture

Figure 2. Global Auxins Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Natural Auxins Product Picture

Figure 4. Synthesis Auxins Product Picture

Figure 5. Global Auxins Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Agriculture

Figure 7. Scientific Research

Figure 8. Others

Figure 9. Auxins Report Years Considered

Figure 10. Global Auxins Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Auxins Revenue (2020-2031) & (US$ Million)

Figure 12. Global Auxins Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Auxins Revenue Market Share by Region (2020-2031)

Figure 14. Global Auxins Sales (2020-2031) & (MT)

Figure 15. Global Auxins Sales (CAGR) by Region (2020-2031) (MT)

Figure 16. Global Auxins Sales Market Share by Region (2020-2031)

Figure 17. Global Auxins Capacity, Production and Utilization (2020-2031) & (MT)

Figure 18. Global Auxins Production Trend by Region (2020-2031) (MT)

Figure 19. Global Auxins Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Auxins Production Growth Rate in North America (2020-2031) & (MT)

Figure 22. Auxins Production Growth Rate in Europe (2020-2031) & (MT)

Figure 23. Auxins Production Growth Rate in China (2020-2031) & (MT)

Figure 24. Auxins Production Growth Rate in Japan (2020-2031) & (MT)

Figure 25. Auxins Production Growth Rate in India (2020-2031) & (MT)

Figure 26. Auxins Production Growth Rate in Southeast Asia (2020-2031) & (MT)

Figure 27. Auxins Production Growth Rate in Brazil (2020-2031) & (MT)

Figure 28. Top 5 and Top 10 Manufacturers Auxins Sales Volume Market Share in 2024

Figure 29. Global Auxins Revenue Market Share Ranking (2024)

Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 31. Natural Auxins Revenue Market Share by Manufacturer in 2024

Figure 32. Synthesis Auxins Revenue Market Share by Manufacturer in 2024

Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 35. Global Auxins Sales Market Share by Type (2020-2031)

Figure 36. Global Auxins Revenue Market Share by Type (2020-2031)

Figure 37. Global Auxins Sales Market Share by Application (2020-2031)

Figure 38. Global Auxins Revenue Market Share by Application (2020-2031)

Figure 39. North America Auxins Sales YoY (2020-2031) & (MT)

Figure 40. North America Auxins Revenue YoY (2020-2031) & (US$ Million)

Figure 41. North America Top 5 Manufacturers Auxins Sales Revenue (US$ Million) in 2024

Figure 42. North America Auxins Sales Volume (MT) by Type (2020- 2031)

Figure 43. North America Auxins Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 44. North America Auxins Sales Volume (MT) by Application (2020-2031)

Figure 45. North America Auxins Sales Revenue (US$ Million) by Application (2020-2031)

Figure 46. US Auxins Revenue (2020-2031) & (US$ Million)

Figure 47. Canada Auxins Revenue (2020-2031) & (US$ Million)

Figure 48. Mexico Auxins Revenue (2020-2031) & (US$ Million)

Figure 49. Europe Auxins Sales YoY (2020-2031) & (MT)

Figure 50. Europe Auxins Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Europe Top 5 Manufacturers Auxins Sales Revenue (US$ Million) in 2024

Figure 52. Europe Auxins Sales Volume (MT) by Type (2020-2031)

Figure 53. Europe Auxins Sales Revenue (US$ Million) by Type (2020-2031)

Figure 54. Europe Auxins Sales Volume (MT) by Application (2020-2031)

Figure 55. Europe Auxins Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Germany Auxins Revenue (2020-2031) & (US$ Million)

Figure 57. France Auxins Revenue (2020-2031) & (US$ Million)

Figure 58. U.K. Auxins Revenue (2020-2031) & (US$ Million)

Figure 59. Italy Auxins Revenue (2020-2031) & (US$ Million)

Figure 60. Russia Auxins Revenue (2020-2031) & (US$ Million)

Figure 61. Asia-Pacific Auxins Sales YoY (2020-2031) & (MT)

Figure 62. Asia-Pacific Auxins Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Asia-Pacific Top 8 Manufacturers Auxins Sales Revenue (US$ Million) in 2024

Figure 64. Asia-Pacific Auxins Sales Volume (MT) by Type (2020- 2031)

Figure 65. Asia-Pacific Auxins Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 66. Asia-Pacific Auxins Sales Volume (MT) by Application (2020-2031)

Figure 67. Asia-Pacific Auxins Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Indonesia Auxins Revenue (2020-2031) & (US$ Million)

Figure 69. Japan Auxins Revenue (2020-2031) & (US$ Million)

Figure 70. South Korea Auxins Revenue (2020-2031) & (US$ Million)

Figure 71. China Taiwan Auxins Revenue (2020-2031) & (US$ Million)

Figure 72. India Auxins Revenue (2020-2031) & (US$ Million)

Figure 73. Central and South America Auxins Sales YoY (2020-2031) & (MT)

Figure 74. Central and South America Auxins Revenue YoY (2020-2031) & (US$ Million)

Figure 75. Central and South America Top 5 Manufacturers Auxins Sales Revenue (US$ Million) in 2024

Figure 76. Central and South America Auxins Sales Volume (MT) by Type (2021-2031)

Figure 77. Central and South America Auxins Sales Revenue (US$ Million) by Type (2020-2031)

Figure 78. Central and South America Auxins Sales Volume (MT) by Application (2020-2031)

Figure 79. Central and South America Auxins Sales Revenue (US$ Million) by Application (2020-2031)

Figure 80. Brazil Auxins Revenue (2020-2025) & (US$ Million)

Figure 81. Argentina Auxins Revenue (2020-2025) & (US$ Million)

Figure 82. Middle East, and Africa Auxins Sales YoY (2020-2031) & (MT)

Figure 83. Middle East and Africa Auxins Revenue YoY (2020-2031) & (US$ Million)

Figure 84. Middle East and Africa Top 5 Manufacturers Auxins Sales Revenue (US$ Million) in 2024

Figure 85. Middle East and Africa Auxins Sales Volume (MT) by Type (2021-2031)

Figure 86. South America Auxins Sales Revenue (US$ Million) by Type (2020-2031)

Figure 87. Middle East and Africa Auxins Sales Volume (MT) by Application (2020-2031)

Figure 88. Middle East and Africa Auxins Sales Revenue (US$ Million) by Application (2020-2031)

Figure 89. GCC Countries Auxins Revenue (2020-2025) & (US$ Million)

Figure 90. Turkey Auxins Revenue (2020-2025) & (US$ Million)

Figure 91. Egypt Auxins Revenue (2020-2025) & (US$ Million)

Figure 92. South Africa Auxins Revenue (2020-2025) & (US$ Million)

Figure 93. Auxins Industry Chain Mapping

Figure 94. Regional Auxins Manufacturing Base Distribution (%)

Figure 95. Auxins Production Process

Figure 96. Regional Auxins Production Cost Structure

Figure 97. Channels of Distribution (Direct Vs Distribution)

Figure 98. Bottom-up and Top-down Approaches for This Report

Figure 99. Data Triangulation

Figure 100. Key Executives Interviewed